ON 09
Alternative Names: ON-09Latest Information Update: 28 Mar 2025
At a glance
- Originator OncoOne
- Class Antineoplastics; Bispecific antibodies; Drug conjugates; Immunoconjugates; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Research Ovarian cancer
Most Recent Events
- 20 Feb 2025 ON 09 is available for licensing as of 20 Feb 2025. https://www.oncoone.com/collaborating/
- 20 Feb 2025 Early research in Ovarian cancer in Austria (Parenteral), prior to February 2025 (OncoOne pipeline, February 2025)